… therapies allow to select specific antiblastics that alone or by integrating the conventional
therapeutic approach … SERPINE1 in PTX drug resistance of breast cancer and appointed it as a …

… prognosis and achieving a better response to therapy. This review focuses on recent studies
on the biological and molecular mechanisms of response and resistance to treatment in BC. …

… lead to inefficiency of endocrine therapy. In this section of the review, we will discuss some
of the molecular mechanisms that may be determinants of endocrine therapy resistance. …

… breast cancers express the estrogen receptor (ERα) and agents targeting this pathway represent
the main treatment … of hormone-responsive breast cancer since its early adoption in the …

… mechanisms in cancer cells and discusses ongoing laboratory approaches and novel
therapeutic … in various cancer types. In this review, we discuss both intrinsic and acquired drug …

… associations and therapeutic approaches in near future. … -resistance in breast cancer via
activation of Akt signaling. Silencing prevents radio-resistance and decreases invasion of breast …

… indicates that a combination of endocrine therapy with other drugs that target different
molecular pathways and coregulators will be one of the most promising treatment approaches. …

… of the molecular mechanisms underlying drug adaptation … to endocrine resistance in breast
cancer through upregulation of … Understandably, before such novel therapeutic approaches …

… underlying mechanisms of chemoresistance in breast cancer … resistance are attributed to
diverse molecular mechanisms, … -apoptosis, autophagy, and other mechanisms (Ji et al., 2019). …

… Triple-negative breast cancer (TNBC) is not a unique disease, encompassing multiple …
the implementation of biomarker-driven therapeutic approaches. However, biomarker-based …